WoodTrust Financial Corp Acquires New Holdings in CVS Health Co. (NYSE:CVS)

WoodTrust Financial Corp bought a new position in CVS Health Co. (NYSE:CVS) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 3,667 shares of the pharmacy operator’s stock, valued at approximately $231,000.

Other institutional investors have also recently made changes to their positions in the company. Cullinan Associates Inc. boosted its stake in shares of CVS Health by 43.8% during the third quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator’s stock valued at $7,125,000 after purchasing an additional 37,395 shares during the period. Deerfield Management Company L.P. Series C purchased a new stake in CVS Health in the second quarter worth about $57,584,000. CX Institutional grew its holdings in shares of CVS Health by 698.0% during the 3rd quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock worth $4,691,000 after acquiring an additional 65,259 shares during the period. Susquehanna Fundamental Investments LLC raised its position in shares of CVS Health by 27.9% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock worth $39,302,000 after acquiring an additional 145,158 shares in the last quarter. Finally, AustralianSuper Pty Ltd boosted its position in shares of CVS Health by 11.0% during the third quarter. AustralianSuper Pty Ltd now owns 1,537,791 shares of the pharmacy operator’s stock valued at $96,696,000 after purchasing an additional 151,901 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on CVS shares. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Truist Financial upped their price objective on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday, October 11th. Deutsche Bank Aktiengesellschaft decreased their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a research report on Wednesday, September 4th. Nine investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $73.11.

CVS Health Trading Up 11.3 %

CVS stock opened at $61.61 on Thursday. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The firm has a market cap of $77.50 billion, a PE ratio of 10.96, a price-to-earnings-growth ratio of 0.82 and a beta of 0.55. The firm has a fifty day moving average price of $59.59 and a 200 day moving average price of $59.23. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $2.21 earnings per share. Sell-side analysts anticipate that CVS Health Co. will post 6.27 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.32%. CVS Health’s dividend payout ratio (DPR) is presently 47.33%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.